Loading...

Meera Chappidi, MD, MPH

TitleResident Physician
InstitutionUniversity of California San Francisco
DepartmentUrology
Address400 Parnassus Avenue
San Francisco CA 94117
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    The Johns Hopkins School of Medicine, Baltimore, MD M.D.05/2017Medicine
    The Johns Hopkins School of Public Health, Baltimore, MDM.P.H.05/2016Epidemiology & Biostatistics
    Brown University, Providence, RISc.B05/2012Neuroscience, Economics

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Joice GA, Chappidi MR, Patel HD, Kates M, Sopko NA, Stimson CJ, Pierorazio PM, Bivalacqua TJ. Hospitalization and Readmission Costs after Radical Cystectomy in a Nationally Representative Sample: Does Urinary Reconstruction Matter? BJU Int. 2018 Jun 13. PMID: 29897156.
      View in: PubMed
    2. Goel R, Chappidi MR, Patel EU, Ness PM, Cushing MM, Frank SM, Tobian AAR. Trends in Red Blood Cell, Plasma, and Platelet Transfusions in the United States, 1993-2014. JAMA. 2018 02 27; 319(8):825-827. PMID: 29486023.
      View in: PubMed
    3. Milbar N, Kates M, Chappidi MR, Pederzoli F, Yoshida T, Sankin A, Pierorazio PM, Schoenberg MP, Bivalacqua TJ. Oncological Outcomes of Sequential Intravesical Gemcitabine and Docetaxel in Patients with Non-Muscle Invasive Bladder Cancer. Bladder Cancer. 2017 Oct 27; 3(4):293-303. PMID: 29152553.
      View in: PubMed
    4. Kates M, Chappidi MR, Brant A, Milbar N, Sopko NA, Meyer C, Terezakis SA, Herman JM, Efron JE, Safar B, Tran PT, Ahuja N, Pierorazio PM, Bivalacqua TJ. High dose-rate Intra-Operative Radiation Therapy During High Risk Genitourinary Surgery: Initial Observations and a Proposal for its Study in Bladder Cancer. Bladder Cancer. 2017 Jul 27; 3(3):191-199. PMID: 28824947.
      View in: PubMed
    5. Pederzoli F, Chappidi MR, Collica S, Kates M, Joice GA, Sopko NA, Montorsi F, Salonia A, Bivalacqua TJ. Analysis of Hospital Readmissions After Prosthetic Urologic Surgery in the United States: Nationally Representative Estimates of Causes, Costs, and Predictive Factors. J Sex Med. 2017 Aug; 14(8):1059-1065. PMID: 28709874.
      View in: PubMed
    6. Tosoian JJ, Chappidi MR, Bishoff JT, Freedland SJ, Reid J, Brawer M, Stone S, Schlomm T, Ross AE. Prognostic utility of biopsy-derived cell cycle progression score in patients with National Comprehensive Cancer Network low-risk prostate cancer undergoing radical prostatectomy: implications for treatment guidance. BJU Int. 2017 12; 120(6):808-814. PMID: 28481440.
      View in: PubMed
    7. Chappidi MR, Kates M, Tosoian JJ, Johnson MH, Hahn NM, Bivalacqua TJ, Pierorazio PM. Evaluation of gender-based disparities in time from initial haematuria presentation to upper tract urothelial carcinoma diagnosis: analysis of a nationwide insurance claims database. BJU Int. 2017 09; 120(3):377-386. PMID: 28418183.
      View in: PubMed
    8. Chappidi MR, Kates M, Sopko NA, Joice GA, Tosoian JJ, Pierorazio PM, Bivalacqua TJ. Erectile Dysfunction Treatment Following Radical Cystoprostatectomy: Analysis of a Nationwide Insurance Claims Database. J Sex Med. 2017 Jun; 14(6):810-817. PMID: 28460994.
      View in: PubMed
    9. Moran D, Wu AW, Connors C, Chappidi MR, Sreedhara SK, Selter JH, Padula WV. Cost-Benefit Analysis of a Support Program for Nursing Staff. J Patient Saf. 2017 Apr 27. PMID: 28452914.
      View in: PubMed
    10. Tosoian JJ, Druskin SC, Andreas D, Mullane P, Chappidi M, Joo S, Ghabili K, Mamawala M, Agostino J, Carter HB, Partin AW, Sokoll LJ, Ross AE. Prostate Health Index density improves detection of clinically significant prostate cancer. BJU Int. 2017 12; 120(6):793-798. PMID: 28058757.
      View in: PubMed
    11. Chappidi MR, Kates M, Bivalacqua TJ. Author Reply. Urology. 2017 04; 102:158. PMID: 28131434.
      View in: PubMed
    12. Tosoian JJ, Druskin SC, Andreas D, Mullane P, Chappidi M, Joo S, Ghabili K, Agostino J, Macura KJ, Carter HB, Schaeffer EM, Partin AW, Sokoll LJ, Ross AE. Use of the Prostate Health Index for detection of prostate cancer: results from a large academic practice. Prostate Cancer Prostatic Dis. 2017 Jun; 20(2):228-233. PMID: 28117387.
      View in: PubMed
    13. Chappidi MR, Kates M, Brant A, Baras AS, Netto GJ, Pierorazio PM, Hahn NM, Bivalacqua TJ. Assessing Cancer Progression and Stable Disease After Neoadjuvant Chemotherapy for Organ-confined Muscle-invasive Bladder Cancer. Urology. 2017 04; 102:148-158. PMID: 28104421.
      View in: PubMed
    14. Matulewicz RS, Tosoian JJ, Stimson CJ, Ross AE, Chappidi M, Lotan TL, Humphreys E, Partin AW, Schaeffer EM. Implementation of a Surgeon-Level Comparative Quality Performance Review to Improve Positive Surgical Margin Rates during Radical Prostatectomy. J Urol. 2017 May; 197(5):1245-1250. PMID: 27916711.
      View in: PubMed
    15. Chappidi MR, Chalfin HJ, Johnson DJ, Kates M, Sopko NA, Johnson MH, Liu JJ, Frank SM, Bivalacqua TJ. Longer average blood storage duration is associated with increased risk of infection and overall morbidity following radical cystectomy. Urol Oncol. 2017 02; 35(2):38.e17-38.e24. PMID: 27771280.
      View in: PubMed
    16. Brant A, Kates M, Chappidi MR, Patel HD, Sopko NA, Netto GJ, Baras AS, Hahn NM, Pierorazio PM, Bivalacqua TJ. Pathologic response in patients receiving neoadjuvant chemotherapy for muscle-invasive bladder cancer: Is therapeutic effect owing to chemotherapy or TURBT? Urol Oncol. 2017 01; 35(1):34.e17-34.e25. PMID: 27639777.
      View in: PubMed
    17. Chappidi MR, Kates M, Stimson CJ, Johnson MH, Pierorazio PM, Bivalacqua TJ. Causes, Timing, Hospital Costs and Perioperative Outcomes of Index vs Nonindex Hospital Readmissions after Radical Cystectomy: Implications for Regionalization of Care. J Urol. 2017 Feb; 197(2):296-301. PMID: 27545575.
      View in: PubMed
    18. Tosoian JJ, Chappidi M, Feng Z, Humphreys EB, Han M, Pavlovich CP, Epstein JI, Partin AW, Trock BJ. Prediction of pathological stage based on clinical stage, serum prostate-specific antigen, and biopsy Gleason score: Partin Tables in the contemporary era. BJU Int. 2017 05; 119(5):676-683. PMID: 27367645.
      View in: PubMed
    19. Chappidi MR, Kates M, Johnson MH, Hahn NM, Bivalacqua TJ, Pierorazio PM. Lymph node yield and tumor location in patients with upper tract urothelial carcinoma undergoing nephroureterectomy affects survival: A U.S. population-based analysis (2004-2012). Urol Oncol. 2016 12; 34(12):531.e15-531.e24. PMID: 27476032.
      View in: PubMed
    20. Chappidi MR, Kates M, Stimson CJ, Bivalacqua TJ, Pierorazio PM. Quantifying Nonindex Hospital Readmissions and Care Fragmentation after Major Urological Oncology Surgeries in a Nationally Representative Sample. J Urol. 2017 Jan; 197(1):235-240. PMID: 27460756.
      View in: PubMed
    21. Kates M, Ball MW, Chappidi MR, Baras AS, Gordetsky J, Sopko NA, Brant A, Pierorazio PM, Epstein JI, Schoenberg MP, Bivalacqua TJ. Accuracy of urethral frozen section during radical cystectomy for bladder cancer. Urol Oncol. 2016 12; 34(12):532.e1-532.e6. PMID: 27432433.
      View in: PubMed
    22. Chappidi MR, Kates M, Patel HD, Tosoian JJ, Kaye DR, Sopko NA, Lascano D, Liu JJ, McKiernan J, Bivalacqua TJ. Frailty as a marker of adverse outcomes in patients with bladder cancer undergoing radical cystectomy. Urol Oncol. 2016 06; 34(6):256.e1-6. PMID: 26899289.
      View in: PubMed